investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Robert I Benezra

The Role of Endothelial Progenitor Cells in Tumor Growth and Metastasis

Non-Hodgkin lymphoma

Robert Yarchoan

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

Non-Hodgkin lymphoma

Marc Nicklaus

In Silico Screening for Cancer Targets

Leukaemia

Pathology Hematology and hematologic malignancies

Wenwei Hu

The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer

Leukaemia

David A Williams

Rac proteins in hematopoietic cell survival and function

Leukaemia

Hematology and hematologic malignancies

Gerd P Pfeifer

5-hydroxymethylcytosine in Human Cancer

Leukaemia

Ann Mullally

Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells

Leukaemia

Danilo Perrotti

Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival

Leukaemia

Hematology and hematologic malignancies Pathology

Harold M Swartz

Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy

Non-Hodgkin lymphoma

Radiation Oncology